TTI
Bearish signal
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Supports a bullish reading. Open-market purchases outweigh sales
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Financial indicators Supports a bullish reading. Current ratio 2.02 · operating margin 9.4%
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Unavailable or mixed. No stored price series
ACHAT TOTAL: 10 000 titres (~65 000,00 $ US)
- Insiders
- John Angela D
- Total bought
-
$65,000
Avg buy (VWAP, 90d window) $6.50 vs last close —
- Total sold
-
—
Avg sell (VWAP, 90d window) $10.72 vs last close —
- Last activity
- 2026-09-02
- Last synced
-
2026-09-08 09:54:45
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-02 | John Angela D | Buy | 10,000 | $6.50 | $65,000 | Form 4 |
| 2026-07-02 | Murphy Brady M | Sell | 61 | $10.01 | $610 | Form 4 |
| 2026-07-01 | Murphy Brady M | Sell | 50,000 | $10.72 | $536,135 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Bearish signalScored 2026-09-03
TTI presents a weak overall profile: a modest insider cluster buy (single purchase, $65k) paired with conference participation offers insufficient catalytic force to offset deeply fragile fundamentals.
The first sentence of the analysis written for TTI on 2026-09-03 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 25.4% | 23.4% | 22.6% | 20.5% | 15.4% | |
| Ebit Margin | 6.9% | 8.5% | 8.6% | 4.9% | 0.4% | |
| Ebitda Margin | 12.8% | 14.5% | 14.1% | 10.8% | 9.1% | |
| Operating Profit Margin | 9.4% | 8.3% | 7.3% | 4.1% | -3.4% | |
| Pretax Profit Margin | 4.2% | 4.8% | 5.1% | 2.0% | -3.8% | |
| Continuous Operations Profit Margin | 0.7% | 19.0% | 4.1% | 1.4% | -4.3% | |
| Net Profit Margin | 0.5% | 18.1% | 4.1% | 1.4% | -4.3% | |
| Bottom Line Profit Margin | 0.5% | 18.1% | 4.1% | 1.4% | -4.3% | |
| Current Ratio | 2.024 | 2.186 | 2.239 | 1.919 | 2.166 | |
| Quick Ratio | 2.024 | 1.361 | 1.472 | 1.339 | 1.454 | |
| Solvency Ratio | 0.080 | 0.310 | 0.171 | 0.116 | 0.056 | |
| Cash Ratio | 0.288 | 0.302 | 0.417 | 0.109 | 0.325 | |
| Price To Earnings Ratio | 414.602 | 4.366 | 22.714 | 56.536 | -21.402 | |
| Price To Earnings Growth Ratio | -4.264 | 0.014 | 0.101 | -0.387 | 0.318 | |
| Forward Price To Earnings Growth Ratio | -4.264 | 0.014 | 0.101 | -0.387 | 0.318 | |
| Price To Earnings Diluted Ratio | 422.072 | 4.366 | 23.003 | 57.285 | -21.402 | |
| Price To Earnings Diluted Growth Ratio | -4.338 | 0.014 | 0.102 | -0.394 | 0.318 | |
| Price To Book Ratio | 4.399 | 1.846 | 3.941 | 4.118 | 3.606 | |
| Price To Sales Ratio | 1.978 | 0.784 | 0.935 | 0.801 | 0.926 | |
| Price To Free Cash Flow Ratio | 63.878 | -19.453 | 18.271 | -21.004 | -22.647 | |
| Price To Operating Cash Flow Ratio | 12.436 | 12.869 | 8.342 | 23.377 | 77.206 | |
| Debt To Assets Ratio | 0.335 | 0.308 | 0.394 | 0.424 | 0.481 | |
| Debt To Equity Ratio | 0.927 | 0.870 | 1.324 | 1.804 | 1.920 | |
| Debt To Capital Ratio | 0.481 | 0.465 | 0.570 | 0.643 | 0.658 | |
| Long Term Debt To Capital Ratio | 0.430 | 0.414 | 0.515 | 0.592 | 0.604 | |
| Financial Leverage Ratio | 2.767 | 2.823 | 3.362 | 4.252 | 3.994 | |
| Working Capital Turnover Ratio | 4.117 | 3.963 | 4.635 | 4.865 | 3.148 | |
| Operating Cash Flow Ratio | 0.641 | 0.296 | 0.557 | 0.153 | 0.048 | |
| Operating Cash Flow Sales Ratio | 0.159 | 0.061 | 0.112 | 0.034 | 0.012 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.195 | -0.662 | 0.457 | -1.113 | -3.409 | |
| Debt Service Coverage Ratio | 1.779 | 4.785 | 2.545 | 2.254 | 1.351 | |
| Interest Coverage Ratio | 3.437 | 2.225 | 2.038 | 1.440 | -0.805 | |
| Short Term Operating Cash Flow Coverage Ratio | 6.420 | 2.717 | 7.071 | 2.077 | 0.574 | |
| Operating Cash Flow Coverage Ratio | 0.381 | 0.165 | 0.357 | 0.098 | 0.024 | |
| Capital Expenditure Coverage Ratio | 1.242 | 0.602 | 1.840 | 0.473 | 0.227 | |
| Dividend Paid And Capex Coverage Ratio | 1.242 | 0.602 | 1.840 | 0.473 | 0.227 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 18.118 | 7.525 | 8.260 | 10.427 | 14.775 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 25.4% | ▲2.0% | ▲3.9% |
| Ebit Margin | 7.0% | ▼-1.6% | ▲1.1% |
| Ebitda Margin | 12.8% | ▼-1.7% | ▲0.6% |
| Operating Profit Margin | 9.4% | ▲1.1% | ▲4.3% |
| Pretax Profit Margin | 4.2% | ▼-0.6% | ▲1.7% |
| Continuous Operations Profit Margin | 0.7% | ▼-18.3% | ▼-3.5% |
| Net Profit Margin | 0.5% | ▼-17.6% | ▼-3.5% |
| Bottom Line Profit Margin | 0.5% | ▼-17.6% | ▼-3.5% |
| Current Ratio | 2.024 | ▼-0.162 | ▼-0.083 |
| Quick Ratio | 2.024 | ▲0.663 | ▲0.494 |
| Solvency Ratio | 0.080 | ▼-0.230 | ▼-0.067 |
| Cash Ratio | 0.287 | ▼-0.014 | ▼-0.001 |
| Price To Earnings Ratio | 414.602 | ▲410.236 | ▲319.239 |
| Price To Earnings Growth Ratio | -4.263 | ▼-4.277 | ▼-3.420 |
| Forward Price To Earnings Growth Ratio | -4.263 | ▼-4.277 | ▼-3.420 |
| Price To Earnings Diluted Ratio | 422.072 | ▲417.706 | ▲325.007 |
| Price To Earnings Diluted Growth Ratio | -4.338 | ▼-4.352 | ▼-3.478 |
| Price To Book Ratio | 4.399 | ▲2.552 | ▲0.817 |
| Price To Sales Ratio | 1.978 | ▲1.194 | ▲0.893 |
| Price To Free Cash Flow Ratio | 63.877 | ▲83.330 | ▲60.069 |
| Price To Operating Cash Flow Ratio | 12.436 | ▼-0.433 | ▼-14.410 |
| Debt To Assets Ratio | 0.335 | ▲0.027 | ▼-0.053 |
| Debt To Equity Ratio | 0.927 | ▲0.058 | ▼-0.442 |
| Debt To Capital Ratio | 0.481 | ▲0.016 | ▼-0.082 |
| Long Term Debt To Capital Ratio | 0.430 | ▲0.016 | ▼-0.081 |
| Financial Leverage Ratio | 2.767 | ▼-0.056 | ▼-0.672 |
| Working Capital Turnover Ratio | 4.117 | ▲0.154 | ▼-0.029 |
| Operating Cash Flow Ratio | 0.641 | ▲0.345 | ▲0.302 |
| Operating Cash Flow Sales Ratio | 0.159 | ▲0.098 | ▲0.083 |
| Free Cash Flow Operating Cash Flow Ratio | 0.195 | ▲0.856 | ▲1.101 |
| Debt Service Coverage Ratio | 1.779 | ▼-3.006 | ▼-0.764 |
| Interest Coverage Ratio | 3.437 | ▲1.212 | ▲1.770 |
| Short Term Operating Cash Flow Coverage Ratio | 6.420 | ▲3.704 | ▲2.648 |
| Operating Cash Flow Coverage Ratio | 0.381 | ▲0.216 | ▲0.176 |
| Capital Expenditure Coverage Ratio | 1.242 | ▲0.640 | ▲0.365 |
| Dividend Paid And Capex Coverage Ratio | 1.242 | ▲0.640 | ▲0.365 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 18.118 | ▲10.592 | ▲6.297 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $1.25B | $470.0M | $585.6M | $443.2M | $359.5M | |
| Enterprise value | $1.47B | $654.2M | $730.0M | $623.7M | $519.5M | |
| EV / Sales | 2.32x | 1.09x | 1.17x | 1.13x | 1.34x | |
| EV / Op. cash flow | 14.61x | 17.91x | 10.40x | 32.90x | 111.55x | |
| EV / Free cash flow | 75.04x | -27.08x | 22.77x | -29.56x | -32.72x | |
| EV / EBITDA | 18.12x | 7.53x | 8.26x | 10.43x | 14.78x | |
| Net debt / EBITDA | 2.69x | 2.12x | 1.63x | 3.02x | 4.55x | |
| Current ratio | 2.02x | 2.19x | 2.24x | 1.92x | 2.17x | |
| Income quality | 23.86x | 0.32x | 2.75x | 2.48x | -0.28x | |
| Graham number | $1 | $6 | $2 | $1 | — | |
| Graham net-net | -$3 | -$2 | -$1 | -$2 | -$1 | |
| Tax burden | 11.3% | 376.7% | 81.3% | 70.2% | 114.1% | |
| Interest burden | 60.5% | 56.1% | 58.6% | 41.4% | -888.9% | |
| Working capital | $160.2M | $146.3M | $156.1M | $114.2M | $113.2M | |
| Invested capital | $412.9M | $343.2M | $324.8M | $282.5M | $276.2M | |
| Return on assets | 0.4% | 15.1% | 5.2% | 1.7% | -4.2% | |
| Operating ROA | 7.9% | 8.2% | 9.5% | 5.3% | -1.7% | |
| Return on tangible assets | 0.4% | 15.6% | 5.5% | 1.8% | -4.7% | |
| Return on equity | 1.1% | 42.5% | 17.4% | 7.3% | -16.9% | |
| Return on invested capital | 1.5% | 8.2% | 9.5% | 4.5% | -4.3% | |
| Return on capital employed | 9.5% | 8.4% | 12.2% | 6.8% | -4.4% | |
| Earnings yield | 0.2% | 23.0% | 4.4% | 1.8% | -4.7% | |
| Free cash flow yield | 1.6% | -5.1% | 5.5% | -4.8% | -4.4% | |
| Capex / Op. cash flow | 80.5% | 166.2% | 54.3% | 211.3% | 440.9% | |
| Capex / Depreciation | 217.9% | 169.9% | 111.1% | 122.1% | 61.3% | |
| Capex / Sales | 12.8% | 10.1% | 6.1% | 7.2% | 5.3% | |
| SG&A / Sales | 15.9% | 15.0% | 15.4% | 16.6% | 19.3% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 1.1% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Intangibles / Total assets | 2.7% | 3.5% | 5.8% | 7.2% | 9.3% | |
| Days sales outstanding | 3d | 64d | 65d | 86d | 86d | |
| Days payables outstanding | 42d | 34d | 39d | 41d | 42d | |
| Operating cycle | 3d | 145d | 138d | 145d | 163d | |
| Cash conversion cycle | -39d | 110d | 98d | 105d | 120d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+165.6%EV / Sales ▲+112.8%EV / EBITDA ▲+140.8%EV / Op. cash flow ▼-3.303Earnings yield ▼-0.228Graham number ▼-4.959
Profitability
Return on equity ▼-0.415Return on assets ▼-0.147Return on invested capital ▼-0.067Return on capital employed ▲+0.011Operating ROA ▼-0.003Income quality ▲+23.534Tax burden ▼-3.654
Efficiency
Days sales outstanding ▼-60.509Days payables outstanding ▲+7.999Operating cycle ▼-141.353Cash conversion cycle ▼-149.352Capex / Sales ▲+0.027R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.162Net debt / EBITDA ▲+0.577Working capital ▲+13936000.000Invested capital ▲+69715000.000Intangibles / Total assets ▼-0.007
Change over 5 years
Valuation
Market cap ▲+247.1%EV / Sales ▲+73.7%EV / EBITDA ▲+22.6%EV / Op. cash flow ▼-96.937Earnings yield ▲+0.049
Profitability
Return on equity ▲+0.179Return on assets ▲+0.046Return on invested capital ▲+0.057Return on capital employed ▲+0.138Operating ROA ▲+0.096Income quality ▲+24.134Tax burden ▼-1.028
Efficiency
Days sales outstanding ▼-82.389Days payables outstanding ▲+0.099Operating cycle ▼-159.175Cash conversion cycle ▼-159.274Capex / Sales ▲+0.075R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.142Net debt / EBITDA ▼-1.853Working capital ▲+46967000.000Invested capital ▲+136719000.000Intangibles / Total assets ▼-0.065
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent news
- 2026-09-03 Thiogenesis Engages Brisco Capital for Investor Relations San Diego, California--(Newsfile Corp. - September 3, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQB: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing sulfur-based therapeutics for rare diseases, today announced that it has engaged Brisco Capital Partners Corp. ("Brisco") to provide investor relations services. Brisco will assist the Company in expanding communications with shareholders, investors and the broader investment community to increase awareness of Thiogenesis and its development programs.
- 2026-09-02 TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES SPRING, Texas, Sept. 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) announced that Brady Murphy, Chief Executive Officer, and Kurt Hallead, Treasurer and VP of Investor Relations, will be meeting with institutional investors at the following conferences: September 9, 2026: Barclays 40th Annual Energy-Power Conference (NY, NY) September 10, 2026: Jefferies Renewables, Clean Energy and E&C Conference (NY, NY) TETRA''s most recent presentation is available on its Investor Relations site.
- 2026-08-31 Technip Energies (OTCMKTS:THNPY) versus Tetra Technologies (NYSE:TTI) Critical Contrast Technip Energies (OTCMKTS:THNPY - Get Free Report) and Tetra Technologies (NYSE: TTI - Get Free Report) are both energy companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, profitability, valuation and risk. Valuation and Earnings This table compares Technip Energies
- 2026-08-19 Tvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Colitis Transcript Tvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Colitis Transcript
- 2026-08-09 Tetra Technologies Q2 Earnings Call Highlights Tetra Technologies NYSE: TTI reported second-quarter revenue of $185.7 million, up 19% sequentially and 7% from the prior-year period, as strength in international and offshore operations offset delayed Middle East fluid shipments tied to regional conflict.
- 2026-08-07 Tetra Technologies (TTI) Reports Q2 Earnings: What Key Metrics Have to Say Although the revenue and EPS for Tetra Technologies (TTI) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 2026-08-04 TETRA Technologies, Inc. (TTI) Q2 2026 Earnings Call Transcript TETRA Technologies, Inc. (TTI) Q2 2026 Earnings Call Transcript
- 2026-08-03 Tetra Technologies (TTI) Q2 Earnings Meet Estimates Tetra Technologies (TTI) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.09 per share a year ago.
- 2026-08-03 Compared to Estimates, Tetra Technologies (TTI) Q2 Earnings: A Look at Key Metrics Although the revenue and EPS for Tetra Technologies (TTI) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 2026-08-03 TETRA TECHNOLOGIES, INC. REPORTS STRONG SECOND-QUARTER 2026 RESULTS SPRING, Texas, Aug. 3, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced financial results for the three and six months ended June 30, 2026. Second-Quarter 2026 Financial Highlights Revenues of $185.7 million Income from continuing operations of $10.2 million, inclusive of $1.1 million of unusual charges Adjusted EBITDA of $31.9 million Net Income per share from continuing operations of $0.07, adjusted net income per share of $0.08 Launched TETRA Neptune Z-Lite, awarded a three-well Gulf of America Deepwater Project Raised $108 million of net proceeds related to the equity offering Board of Directors approved final investment decision ("FID") for the Arkansas Bromine Project Brady Murphy, TETRA''s President and Chief Executive Officer, stated, "We delivered one of our strongest second-quarter and first-half financial performances in the past decade, reflecting the strength of our base business and our ability to grow in deepwater and international markets.